首页> Journal of the advanced practitioner in oncology> Elotuzumab: The First Monoclonal Antibody for the Treatment of Multiple Myeloma.

Elotuzumab: The First Monoclonal Antibody for the Treatment of Multiple Myeloma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Karen M,Fancher

第一单位： 1Duquesne University Mylan School of Pharmacy, Pittsburgh, Pennsylvania; 2University of Pittsburgh Medical Center Passavant, Pittsburgh, Pennsylvania.

作者： Karen M,Fancher ^[1] ; Elizabeth J,Bunk ^[1]

作者单位： 1Duquesne University Mylan School of Pharmacy, Pittsburgh, Pennsylvania; 2University of Pittsburgh Medical Center Passavant, Pittsburgh, Pennsylvania. ^[1]

DOI 10.6004/jadpro.2016.7.5.6

PMID 29282429

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of the advanced practitioner in oncology

542-547页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of the advanced practitioner in oncology

542-547页

检索历史清除

Elotuzumab: The First Monoclonal Antibody for the Treatment of Multiple Myeloma.

Journal of the advanced practitioner in oncology

相似文献

同项目论文

Journal of the advanced practitioner in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Elotuzumab: The First Monoclonal Antibody for the Treatment of Multiple Myeloma.

Journal of the advanced practitioner in oncology

相似文献

同项目论文

Journal of the advanced practitioner in oncology

相关期刊

检索历史清除